Sfoglia per AUTORE
AIROLDI M
Collezione ASL Città di Torino

  

Items : 20

Impact of the pandemic on surgical oncology in Piedmont, Italy: A retrospective observational study. in Journal of surgical oncology / J Surg Oncol. 2024 May;129(6):1165-1170. doi: 10.1002/jso.27606. Epub 2024 Feb 28.

2024
ASL Città di Torino

Aglietta M; Airoldi M; Comandone A; Previti C; Ragusa P; Lo Moro G; Siliquini R;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Maio MD; Buttigliero C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Ruatta F; Tucci M; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; et alii...

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies in Breast Care

2020
ASL Città di Torino

Pronzato P; Mustacchi G; Torri V; Marchetti P; Romagnoli E; Riccardi F; Natoli C; Montemurro F; Livi L; Bisagni G; Del Mastro L; Biganzoli L; Giordano M; Donadio M; Clivio L; Scavelli C; Frassoldati A; Ferzi A; Palumbo R; Gebbia V; Schirone A; Fabi A; Santini D; Porpiglia M; Turletti A; De Laurentiis M; Atzori F; Artale S; Blasi L; et alii...

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Oct 2;9(77):34639-34640. doi: 10.18632/oncotarget.26213. eCollection 2018 Oct 2.

2018
ASL Città di Torino
AO Cuneo

Clivio L; Torri On Behalf Of The Eva Study Group V; Frassoldati A; Scavelli C; Palumbo R; Ferzi A; Schirone A; Cursano MC; Fabi A; Gebbia V; Benedetto C; Atzori F; Turletti A; Blasi L; Piezzo M; Artale S; Mentuccia L; La Verde N; Bianchi G; Musolino A; Vici P; Maur M; Pistelli M; Garrone O; Generali D; Zambelli A; Febbraro A; Arcangeli V; Diodati L; et alii...

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431. eCollection 2018 Nov 30.

2018
ASL Città di Torino
AO Cuneo

Torri V; Frassoldati A; Clivio L; Scavelli C; Ferzi A; Palumbo R; Gebbia V; Schirone A; Fabi A; Benedetto C; Cursano MC; Turletti A; Atzori F; Artale S; Blasi L; Piezzo M; Bianchi G; Maur M; La Verde N; Mentuccia L; Vici P; Musolino A; Pistelli M; Garrone O; Generali D; Zambelli A; Febbraro A; Arcangeli V; Diodati L; et alii...

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Aug 7;9(61):31877-31887. doi: 10.18632/oncotarget.25874. eCollection 2018 Aug 7.

2018
ASL Città di Torino
AO Cuneo

Torri On Behalf Of The Eva Study Group V; Clivio L; Scavelli C; Frassoldati A; Ferzi A; Palumbo R; Gebbia V; Schirone A; Fabi A; Cursano MC; Turletti A; Benedetto C; Atzori F; Piezzo M; Artale S; Blasi L; La Verde N; Bianchi G; Maur M; Mentuccia L; Vici P; Musolino A; Garrone O; Pistelli M; Zambelli A; Febbraro A; Generali D; Diodati L; Arcangeli V; et alii...

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: New lessons for clinical practice from the EVA study in Oncotarget

2018
ASL Città di Torino

Torri V; Clivio L; Frassoldati A; Scavelli C; Ferzi A; Palumbo R; Schirone A; Gebbia V; Fabi A; Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Artale S; Blasi L; Bianchi G; Mentuccia L; La Verde N; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Zambelli A; Febbraro A; Arcangeli V; Diodati L; et alii...

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) in Oncotarget

2018
ASL Città di Torino

Torri V; Clivio L; Scavelli C; Ferzi A; Frassoldati A; Palumbo R; Schirone A; Gebbia V; Fabi A; Cursano MC; Benedetto C; Turletti A; Atzori F; Blasi L; Piezzo M; Artale S; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; et alii...

Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874) in Oncotarget

2018
ASL Città di Torino

Torri V; Clivio L; Scavelli C; Ferzi A; Frassoldati A; Palumbo R; Schirone A; Fabi A; Gebbia V; Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Blasi L; Artale S; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; et alii...

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. in Breast (Edinburgh, Scotland) / Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.

2017
AO Cuneo
ASL Città di Torino

Clivio L; Zambelli A; Blasi L; Torri V; Sartori D; Scavelli C; Schirone A; Turletti A; Vici P; Valerio MR; Palumbo R; Pistelli M; Musolino A; Porpiglia M; Arcangeli V; Artale S; Atzori F; Ballerio A; Bianchi GV; Moretti G; Maur M; Michelotti A; La Verde N; Generali D; Gebbia V; Garrone O; Fumagalli A; Frassoldati A; Ficorella C; et alii...

Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases. in American journal of clinical oncology / Am J Clin Oncol. 2017 Feb;40(1):86-90. doi: 10.1097/COC.0000000000000112.

2017
AOU Città della Salute di Torino
ASL Città di Torino

Riva G; Succo G; Ostellino O; Garzaro M; Pedani F; Airoldi M; Raimondo L; Pecorari G; Sensini M; Naqe N; Bellini E;

Nab-paclitaxel in clinical practice: Data from the MANTEL study in Annals of Oncology

2017
ASL Asti
ASL Città di Torino
ASL Torino 4
AOU Città della Salute di Torino

Vanella P; Garrone O; Saggia C; Bergnolo P; Beano A; Airoldi M; Turletti A; Castiglione F; Manzin E; Denaro N; De Conciliis E; Vandone AM; Donadio M; Miraglio E; Merlano MC; Cursano MC; De Angelis C; Giarratano T; Cazzaniga M; La Verde N; Milani A; Collová E; Coltelli L; D'Onofrio L; Bertolini I; Guarneri V; Riva F; Mustacchi G; Giordano M; et alii...

Nab-paclitaxel in clinical practice: data from the MANTEL study in Annals of oncology : official journal of the European Society for Medical Oncology

2017
ASL Città di Torino
ASL Torino 4

Vanella P; Garrone O; Saggia C; Bergnolo P; Beano A; Airoldi M; Turletti A; Castiglione F; Manzin E; Denaro N; de Conciliis E; Vandone AM; Donadio M; Miraglio E; Merlano MC;

Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma in Cancer Chemotherapy and Pharmacology

2011
ASL Città di Torino

Airoldi M; Gabriele P; Gabriele AM; Garzaro M; Raimondo L; Pedani F; Beatrice F; Pecorari G; Giordano C;

Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population in Radiotherapy and Oncology

2009
ASL Città di Torino

Airoldi M; Gabriele AM; Garzaro M; Raimondo L; Condello C; Beatrice F; Pecorari G; Giordano C;

Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. in Oncology / Oncology. 2009;76(4):262-9. doi: 10.1159/000206140. Epub 2009 Mar 4.

2009
ASL Città di Torino
ASL Torino 3

Beatrice F; Gabriele AM; Gabriele P; Pecorari G; Giordano C; Mamo C; Bena A; Valente G; Garzaro M; Airoldi M;

Oropharyngeal carcinoma during pregnancy: clinical and psycho-oncological aspects. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2003 Dec;23(6):440-5.

2003
ASL Città di Torino

Siri I; Torta R; Crosetti E; Succo G; Di Lisi D; Sartoris A; Airoldi M;

Docetaxel and vinorelbine in recurrent head and neck cancer: Pharmacokinetic and clinical results in American Journal of Clinical Oncology: Cancer Clinical Trials

2003
ASL Città di Torino

Airoldi M; Cattel L; Marchionatti S; Recalenda V; Pedani F; Tagini V; Bumma C; Beatrice F; Succo G; Gabriele AM;

Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma in Tumori

2002
ASL Città di Torino

Gabriele P; Rosmino C; Amasio E; Bongioannini G; Airoldi M; Mairone L; Artusio E; Fornari G;

Combined chemo-radiotherapy for stage IV undifferentiated nasopharyngeal carcinoma. in Tumori

2000
ASL Città di Torino

Gabriele AM; Airoldi M; Beatrice F; Trotti AB;